Company intelligence / Profile preview

Caligenix

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Caligenix offers fully commercial DNA/RNA biomarker tests with proprietary robotics/AI, personalized supplement and skincare recommendations, and environmental health analytics. Products like Immunotype (for immunity), Dermatype, and Biotype (for skin/nutrition) utilize genomic data for scientifically individualized recommendations. No classical clinical trial data, as diagnostics/supplements in the wellness/lifestyle space.

Therapeutic areas: OtherDermatologyImmunology
Modalities: Diagnostic testDevice (DNA + RNA biomarker test)Supplementation (nutritional supplement formulation)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Caligenix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caligenix.

Explore the full profile